Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer

Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer

Abstract Background The clinicopathological features of MET‐amplified gastric cancer (GC) and real‐world data on the efficacy of MET‐targeted therapies remain unknown. Pulmonary lymphangitis carcinomatosis (PLC) is a peculiar manifestation of GC, whose management has not been thoroughly described. M...

Full description

Bibliographic Details
Main Authors:	Zhening Zhang, Yiyi Yu, Tong Xie, Changsong Qi, Xiaotian Zhang, Lin Shen, Zhi Peng
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Cancer Medicine
Subjects:	gastric cancer heterogeneity MET amplification pulmonary lymphangitis carcinomatosis targeted therapy
Online Access:	https://doi.org/10.1002/cam4.6575

Similar Items

A rare case of lymphangitis carcinomatosis presenting as diffuse parenchymal lung disease
by: P Maheswari, et al.
Published: (2023-01-01)

Retrospective Analysis of Lymphangitis Carcinomatosa Regarding Primer Tumor Spectrum and Computer Tomography Features
by: Mesut Özgökce, et al.
Published: (2017-05-01)

COMPARATIVE EFFICACY OF NORMAL DRESSINGAND COLLAGEN DRESSING IN CHRONIC ULCERATIVE LYMPHANGITIS IN EQUINE
by: F. Mridha, et al.
Published: (2022-12-01)

Delineating the boundaries of superficial lymphangitis: A retrospective study of 11 cases with a review of literature
by: Reena K Sharma, et al.
Published: (2023-01-01)

Breast Carcinomatous Lymphangitis as an Unusual Presentation of Ovarian Cancer
by: Barbara Muoio, et al.
Published: (2021-11-01)

Imaging of Gastric Carcinomatosis
by: Raquel Saiz Martínez, et al.
Published: (2021-11-01)

Targeted therapy for multiple gene mutations in multiple metastases of advanced gastric cancer: a case report
by: Xin Zhang, et al.
Published: (2023-12-01)

Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer
by: Seonggyu Byeon, et al.
Published: (2023-11-01)

Laparoscopic Heated Intraperitoneal Chemotherapy in the Treatment of Carcinomatosis of Gastric Adenocarcinoma Origin
by: Michael G. White, et al.
Published: (2021-10-01)

Ulcerative Lymphangitis in a 12 Year Old Stallion in Ibadan, Nigeria A Case Study
by: Edward Olajide, et al.
Published: (2023-04-01)

Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic
by: Roberta Fusco, et al.
Published: (2022-04-01)

A case of metastatic leptomeningeal carcinomatosis from early gastric carcinoma
by: Park Kwang-Kuk, et al.
Published: (2012-05-01)

Lymphangitis in a Portuguese Patient Infected with Rickettsia sibirica
by: Rita de Sousa, et al.
Published: (2008-03-01)

Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature
by: Daniel S Lefler, et al.
Published: (2022-12-01)

Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis
by: V. A. Markovich, et al.
Published: (2023-02-01)

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
by: Thomas Boerner, et al.
Published: (2021-11-01)

Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies
by: Courtney Chen, et al.
Published: (2023-11-01)

Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis
by: Guangmin Guan, et al.
Published: (2022-10-01)

Pulmonary Lymphangitis Carcinomatosa Mimicking Immunotherapy-Related Interstitial Pneumonitis: A Case Report
by: Takuma Imakita, et al.
Published: (2022-08-01)

Regional Immunotherapy for Peritoneal Carcinomatosis in Gastroesophageal Cancer: Emerging Strategies to Re-Condition a Maladaptive Tumor Environment
by: Catherine R. Lewis, et al.
Published: (2023-10-01)

Research Progresses in the Treatment of NSCLC with MET Gene Variants: A Riview
by: Ran CHEN, et al.
Published: (2022-12-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Additional Information Helps to Optimize Patient Selection before Surgery
by: Hao-Chien Hung, et al.
Published: (2023-03-01)

Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
by: Maheswari Senthil, et al.
Published: (2023-03-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01)

Prevalence and risk factors of epizootic lymphangitis in cart pulling horses and mules in Central and South Gondar zones, Amhara region, Ethiopia
by: Amsalu Misgie Molla, et al.
Published: (2022-08-01)

The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications
by: Siyuan Qian, et al.
Published: (2021-10-01)

Responses to the Tepotinib in Gastric Cancers with MET Amplification or MET Exon 14 Skipping Mutations and High Expression of Both PD-L1 and CD44
by: Sung-Hwa Sohn, et al.
Published: (2022-07-01)

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target
by: Gianluca Spitaleri, et al.
Published: (2023-09-01)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with <i>MET</i> Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
by: Wei Yin, et al.
Published: (2022-05-01)

TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
by: Jia Li, et al.
Published: (2021-04-01)

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
by: Hsin-Hsien Yu, et al.
Published: (2023-06-01)

Unravelling Peritoneal Carcinomatosis Using Cross-Sectional Imaging Modalities
by: Ana Veron Sanchez, et al.
Published: (2023-07-01)

Peritoneal splenosis, simulating carcinomatosis
by: Sh. V. Timerbulatov, et al.
Published: (2020-08-01)

SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
by: Katia De Marco, et al.
Published: (2023-10-01)

Compresión medular metastásica y carcinomatosis leptomeníngea
by: Josep Dalman
Published: (2019-09-01)

Peritoneal carcinomatosis mimicking a perforated diverticulitis
by: Olivier Facy, et al.
Published: (2011-04-01)

Intraabdominal Tuberculosis Cases Presenting with Peritoneal Carcinomatosis
by: Nazlım AKTUĞ DEMİR, et al.
Published: (2020-06-01)

Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy
by: Sungho Kim, et al.
Published: (2022-05-01)

The Role of cMET in Gastric Cancer—A Review of the Literature
by: Filip Van Herpe, et al.
Published: (2023-03-01)

Targeting <i>MET</i> Amplification: Opportunities and Obstacles in Therapeutic Approaches
by: Yuichi Kumaki, et al.
Published: (2023-09-01)